BackVericel Overview
Vericel Corp

Vericel Target Price

Where could VCEL trade next? Consensus target price: $57.

Get informed when a big investor buys or sells

+ Follow

Share Price

$44.73

Average Target Price

$56.5026.3% upside

4 analysts in the last 4 months

High: $70 | Low: $42

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-07-30Canaccord GenuityCaitlin Cronin$6034.1% upsideOpen
2026-07-16Truist FinancialRichard Newitter$5420.7% upsideOpen
2026-05-08H.C. Wainwright$7056.5% upsideOpen
2026-04-15Truist Financial$426.1% downsideOpen
2026-03-10Leerink PartnersMike Kratky$462.8% upsideOpen
2025-12-18Truist FinancialRichard Newitter$450.6% upsideOpen
2025-10-15Truist Financial$418.3% downsideOpen
2024-12-18Truist FinancialRichard Newitter$6749.8% upsideOpen
2024-08-26BTIGRyan Zimmerman$5523% upsideOpen
2024-08-02H.C. WainwrightSwayampakula Ramakanth$6034.1% upsideOpen
2024-07-16Truist FinancialRichard Newitter$5727.4% upsideOpen
2024-07-05BTIGRyan Zimmerman$5625.2% upsideOpen
2024-01-25Truist FinancialSamuel Brodovsky$5114% upsideOpen
2023-01-03H.C. Wainwright$3717.3% downsideOpen
2022-12-20Truist Financial$2544.1% downsideOpen
2022-07-18BTIG$3424% downsideOpen

Vericel (VCEL) FAQ

Vericel's target price stands at $57. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

The Street's average target of $57 for VCEL implies 26.3% upside versus today's price ($44.73). Positive implied upside usually reflects optimism on growth or margins, while a large downside can signal valuation or fundamental concerns. Check recommendation mix and recent target changes for more context.

The history chart shows how Vericel's target price evolved across reporting periods, while the comparison chart places VCEL next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, target price is commonly used to spot outliers. Vericel's reading of $57 is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.